Orest Olejnik
59Patents
19h-index
30Co-inventors
84Inventor score
Filing activity: Jul 11, 1985 → Mar 31, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6074661A | Sterile bioerodible occular implant device with a retinoid for improved biocompatability | Human Necessities | 167 | Expired |
| US5474979A | Nonirritating emulsions for sensitive tissue | Human Necessities | 146 | Expired |
| US6537568B2 | Implant device with a retinoid for improved biocompatibility | Human Necessities | 136 | Expired |
| US6455062B1 | Implant device with a retinoid for improved biocompatibility | Human Necessities | 108 | Expired |
| US6306426A | Implant device with a retinoid for improved biocompatibility | Human Necessities | 105 | Expired |
| US5981607A | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers | Human Necessities | 97 | Expired |
| US6562873B2 | Compositions containing therapeutically active components having enhanced solubility | Human Necessities | 52 | Expired |
| US7288520B2 | Cyclosporin compositions | Human Necessities | 38 | Expired |
| US6627210B2 | Compositions containing &agr;-2-adrenergic agonist components | Human Necessities | 37 | Expired |
| US8147865B2 | Steroid-containing sustained release intraocular implants and related methods | Human Necessities | 34 | Active |
| US6358935B1 | Preserved cyclodextrin-containing compositions | Human Necessities | 27 | Expired |
| US6641834B2 | Compositions containing alpha-2-adrenergic agonist components | Human Necessities | 27 | Expired |
| US5290781A | Ketaneserinol as an agent to reduce intraocular pressure | Human Necessities | 27 | Expired |
| US6110485A | Sterile bioerodible implant device with a retinoid for improved biocompatability | Human Necessities | 26 | Expired |
| US6673337B2 | Compositions containing alpha-2-adrenergic agonist components | Human Necessities | 26 | Expired |
| US7202209B2 | Cyclosporin compositions | Human Necessities | 25 | Expired |
| US7297679B2 | Cyclosporin compositions | Human Necessities | 25 | Expired |
| US8211855B2 | Cyclosporin compositions | Human Necessities | 21 | Active |
| US7276476B2 | Cyclosporin compositions | Human Necessities | 21 | Expired |
| US5597559A | Ophthalmic formulation | Human Necessities | 18 | Expired |
| US6723353B2 | Preserved cyclodextrin-containing compositions | Human Necessities | 18 | Expired |
| US6984628B2 | Ophthalmic compositions comprising trefoil factor family peptides | Human Necessities | 16 | Expired |
| US8288348B2 | Cyclosporin compositions | Human Necessities | 16 | Active |
| US9101574B2 | Cyclosporin compositions | Human Necessities | 12 | Active |
| US7384648B2 | Implant device with a retinoid for improved biocompatibility | Human Necessities | 8 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.